NYSE:EVH - Evolent Health Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$13.33 -0.67 (-4.79 %)
(As of 03/24/2019 03:41 PM ET)
Previous Close$13.33
Today's Range$13.27 - $14.26
52-Week Range$12.09 - $29.05
Volume1.49 million shs
Average Volume1.87 million shs
Market Capitalization$1.10 billion
P/E Ratio-38.09
Dividend YieldN/A

Analyst Ratings

Evolent Health (NYSE:EVH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Evolent Health in the last 12 months. Their average twelve-month price target is $27.15, suggesting that the stock has a possible upside of 103.68%. The high price target for EVH is $35.00 and the low price target for EVH is $20.00. There are currently 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $27.15$32.4444$32.4444$28.70
Price Target Upside: 103.68% upside64.61% upside41.93% upside3.99% upside

Evolent Health (NYSE:EVH) Consensus Price Target History

Price Target History for Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/4/2019KeyCorpLower Price TargetOverweight ➝ Overweight$32.00 ➝ $20.00HighView Rating Details
2/27/2019OppenheimerLower Price TargetOutperform$31.00 ➝ $21.00LowView Rating Details
2/27/2019Wells Fargo & CoLower Price TargetOutperform$34.00 ➝ $21.50HighView Rating Details
2/27/2019Cantor FitzgeraldLower Price TargetOverweight ➝ Overweight$37.00 ➝ $20.00HighView Rating Details
11/7/2018Piper Jaffray CompaniesReiterated RatingOverweight$34.00HighView Rating Details
10/5/2018Leerink SwannSet Price TargetOutperform ➝ Buy$35.00MediumView Rating Details
10/4/2018CitigroupBoost Price TargetPositive ➝ Buy$25.00 ➝ $32.00MediumView Rating Details
9/13/2018Canaccord GenuityBoost Price TargetBuy$24.00 ➝ $28.00LowView Rating Details
9/13/2018CowenBoost Price TargetOutperform$29.00 ➝ $35.00HighView Rating Details
8/7/2018Jefferies Financial GroupReiterated RatingBuy$25.00HighView Rating Details
6/7/2018SunTrust BanksBoost Price TargetBuyLowView Rating Details
11/7/2017Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyN/AView Rating Details
11/1/2017Robert W. BairdReiterated RatingBuy$25.00N/AView Rating Details
8/18/2017JPMorgan Chase & Co.Reiterated RatingBuyLowView Rating Details
(Data available from 3/24/2017 forward)
This page was last updated on 3/24/2019 by MarketBeat.com Staff

Featured Article: Inflation

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel